Induction of Labor in Morbidly Obese Patients

Recruiting now · Early Phase 1

Conditions studied: Morbid Obesity, Pregnancy

In brief

The goal of this randomized control trial is to compare different doses of Misoprostol (25 mcg vs 50 mcg) in induction of labor (IOL) in morbidly obese patients with BMI \>40. It is known that morbid obesity is a risk factor for failed IOL and ultimately cesarean delivery (CD.) If the rates of vaginal delivery in this population can improve, then surgical morbidity can be reduced in these patients.

Key facts

Study ID
NCT06199154
Run by
University of Maryland, Baltimore
People needed
162
Starts
2024-07-15
Expected to finish
2027-05-01
Last updated by the study team
2026-07-29

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.